Story

ADENTRA Named Top Pick in Canadian Forest Products by TD Cowen

ENTHMSVIIDZHZH-TWJAKOHI
Sep 22, 20261 min read
ADENTRA Named Top Pick in Canadian Forest Products by TD Cowen

Summary

TD Cowen has designated ADENTRA as its 'Canada Best Idea' in the Paper & Forest Product sector, citing a clear path for EBITDA recovery and free cash flow-driven deleveraging through 2027.

Text size
Background

Investment firm TD Cowen has named ADENTRA its top pick in Canada's Paper & Forest Product sector, identifying a clear path for equity value creation through 2027 based on earnings recovery and debt reduction.

TD Cowen's Investment Thesis

According to a note from the firm, the investment thesis for ADENTRA centers on two key drivers: a recovery in EBITDA from cyclical lows and deleveraging fueled by strong free cash flow. TD Cowen positions the company as a lower-risk investment for gaining exposure to an eventual rebound in the new housing and repair/remodel markets.

The firm's analysis suggests the market currently underestimates ADENTRA's ability to generate value, even within a subdued housing environment. The core of the investment case rests on the company's fundamental ability to improve earnings and pay down debt over the next several years.

Differentiating Factors

TD Cowen highlighted several operational strengths that distinguish ADENTRA from its peers in the sector:

Sample IUX Markets – In-articleAd
  • A capital-light distribution model that reduces financial risk.
  • A specialty-focused product mix that provides more stability than commodity-based players.
  • Significant working capital flexibility, which supports resilient free cash flow generation despite operating in cyclical end-markets.

While the firm sees potential upside from disciplined mergers and acquisitions (M&A) and an expansion of the company's valuation multiple, it noted these factors are not incorporated into its base case estimates.

Recent Performance

The positive outlook from TD Cowen follows a strong recent financial report from ADENTRA. For the second quarter of 2026, the company reported results that surpassed analyst expectations, posting adjusted earnings of $0.96 per share on revenue of $607.1 million.

Read next

More on Stocks
Back to latest news

LATEST